Addition Therapeutics

Developer of RNA-mediated genetic medicines

placeSan Francisco, California, United States calendar_todayFounded 2021 language additiontx.com

Social engagement

Social engagement: 5.3K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital583%
Other / undisclosed117%

Recent activity

12 May 2026
Event
American Society of Gene & Cell Therapy 29th Annual Meeting
27 Apr 2026
Event
ASGCT 29th Annual Meeting
15 Apr 2026
Event
Endpoints News Discovery Day 2026 'Beyond CRISPR' panel on genetic medicine technologies
Coming soon